236 related articles for article (PubMed ID: 32996552)
1. Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy.
Ma BA; Sun CY
J Mater Chem B; 2020 Oct; 8(40):9351-9361. PubMed ID: 32996552
[TBL] [Abstract][Full Text] [Related]
2. Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic-Chemo Combination Therapy.
Yang DC; Wang S; Weng XL; Zhang HX; Liu JY; Lin Z
ACS Appl Mater Interfaces; 2021 Jul; 13(29):33905-33914. PubMed ID: 34278780
[TBL] [Abstract][Full Text] [Related]
3. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy.
Sun CY; Zhang BB; Zhou JY
J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968
[TBL] [Abstract][Full Text] [Related]
4. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
5. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
7. Dual-Responsive and ROS-Augmented Nanoplatform for Chemo/Photodynamic/Chemodynamic Combination Therapy of Triple Negative Breast Cancer.
Chen M; Yang J; Zhou L; Hu X; Wang C; Chai K; Li R; Feng L; Sun Y; Dong C; Shi S
ACS Appl Mater Interfaces; 2022 Jan; 14(1):57-68. PubMed ID: 34935343
[TBL] [Abstract][Full Text] [Related]
8. A Reactive (1)O2 - Responsive Combined Treatment System of Photodynamic and Chemotherapy for Cancer.
Wang X; Meng G; Zhang S; Liu X
Sci Rep; 2016 Jul; 6():29911. PubMed ID: 27443831
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of doxorubicin modified ZnO/PEG nanomaterials and its photodynamic action.
Hariharan R; Senthilkumar S; Suganthi A; Rajarajan M
J Photochem Photobiol B; 2012 Nov; 116():56-65. PubMed ID: 22982207
[TBL] [Abstract][Full Text] [Related]
10. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
[TBL] [Abstract][Full Text] [Related]
11. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
Gao D; Lo PC
J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
[TBL] [Abstract][Full Text] [Related]
12. Novel pH-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.
Zheng K; Liu X; Liu H; Dong D; Li L; Jiang L; Huang M; Ding C
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10674-10688. PubMed ID: 33621058
[TBL] [Abstract][Full Text] [Related]
13. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia- and singlet oxygen-responsive chemo-photodynamic Micelles featured with glutathione depletion and aldehyde production.
Deng J; Liu F; Wang L; An Y; Gao M; Wang Z; Zhao Y
Biomater Sci; 2018 Dec; 7(1):429-441. PubMed ID: 30500010
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
16. Photoresponsive Micelle-Incorporated Doxorubicin for Chemo-Photodynamic Therapy to Achieve Synergistic Antitumor Effects.
Kim DH; Hwang HS; Na K
Biomacromolecules; 2018 Aug; 19(8):3301-3310. PubMed ID: 29864270
[TBL] [Abstract][Full Text] [Related]
17. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
18. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
Chen Y; Gao Y; Li Y; Wang K; Zhu J
J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
[TBL] [Abstract][Full Text] [Related]
19. Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties.
Chen H; Luo Q; Wang J; He H; Luo W; Zhang L; Xiao Q; Chen T; Xu X; Niu W; Ke Y; Wang Y
ACS Appl Mater Interfaces; 2020 May; 12(20):22673-22686. PubMed ID: 32337980
[TBL] [Abstract][Full Text] [Related]
20. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
